AEON Biopharma (AEON) Q1 2026 Earnings
AEON·Reported May 14, 2026·Before market open
Diluted EPS came in at $-0.44 (-388.9% YoY).
Diluted EPS
$-0.44met estimate
Consensus: $-0.44
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about AEON Biopharma's Q1 2026 earnings report.
AEON Biopharma (AEON) reported Q1 2026 earnings on May 14, 2026 before market open.
AEON Biopharma reported diluted EPS of $-0.44 for Q1 2026.
EPS beat the consensus estimate of $-0.44 by $0.00.
Compared to the same quarter a year prior, diluted EPS declined 388.9% from $-0.09.
You can read the 8-K earnings release (0001837607-26-000041) and the 10-Q periodic report (0001837607-26-000042) directly on SEC EDGAR. The filing index links above go to sec.gov.